These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21659823)

  • 1. Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity.
    Angeli F; Reboldi G; Verdecchia P
    J Hypertens; 2011 Jul; 29(7):1298-302. PubMed ID: 21659823
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication.
    Diehm C; Pittrow D; Lawall H
    J Hypertens; 2011 Jul; 29(7):1448-56. PubMed ID: 21602713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of nebivolol.
    Janssens WJ
    J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
    Gromnatskiĭ NI; Dius'mikeeva NB
    Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol and endothelium dysfunction in salt-sensitive Dahl rats.
    van Zwieten PA
    J Hypertens; 2002 Mar; 20(3):357. PubMed ID: 11875295
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.
    Kamp O; Sieswerda GT; Visser CA
    Am J Cardiol; 2003 Aug; 92(3):344-8. PubMed ID: 12888152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
    Toblli JE; Cao G; Casas G; Mazza ON
    Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.
    Schmidt AC; Graf C; Brixius K; Scholze J
    Clin Drug Investig; 2007; 27(12):841-9. PubMed ID: 18020542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory mechanisms of beta receptor blockade.
    Rath G; Balligand JL; Dessy C
    Curr Hypertens Rep; 2012 Aug; 14(4):310-7. PubMed ID: 22639015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD; Wagstaff AJ
    Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A; Nuzum DS; Jolly JL
    Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of intracerebroventricular injections of (+/-)-nebivolol and its enantiomers--a comparison with those of metoprolol in the rat.
    Midol-Monnet M; Davy M; Heimburger M; Beslot F; Cohen Y
    J Pharm Pharmacol; 1991 Jul; 43(7):504-9. PubMed ID: 1682465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of nebivolol on dynamics of microalbuminuria, renal blood flow and 24-hour blood pressure profile in patients with hypertension].
    Gromnatskiĭ NI; Vasil'eva DA
    Kardiologiia; 2002; 42(9):53-6. PubMed ID: 12494075
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.
    Xhonneux R; Wouters L; Reneman RS; Janssen PA
    Eur J Pharmacol; 1990 Jun; 181(3):261-5. PubMed ID: 1974517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.